INS and type 2 diabetes mellitus: Other clinical trials in which participants were enrolled with disturbed glucose homeostasis, such as patients with T2D, the metabolic syndrome, or decreased insulin sensitivity, also did not find improvement in IHL upon resveratrol treatment (14, 36, 45, 46).